Clinical Trial Update: IFCT-GFPC 05.02 A Randomized Phase III Trial Assessing in Patients With Advanced Non-small Cell Lung Cancer [Phase 3]

View source ↗

Summary

A randomized Phase III trial evaluating treatments in patients with advanced stage IV non-small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Stage IV Non-small Cell Lung Cancer | Phase 3 | Status: COMPLETED